Codex DNA to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
November 02 2021 - 7:00AM
Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop
synthetic biology systems, today announced that it will release its
third quarter 2021 financial results on Tuesday, November 9, 2021,
after the market closes. In conjunction with the release,
management will host a conference call on Tuesday, November 9,
2021, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss
the financial results and recent corporate highlights.
The press release and live audio webcast can be accessed via the
Investor section of the Company’s website at www.codexdna.com. The
conference call can be accessed by dialing (888) 705-0127
(domestic) or (409) 937-8880 (international) and referring to
conference ID 3669005. Please log in approximately 5 to 10 minutes
before the event to ensure a timely connection. The archived
webcast will remain available for replay on Codex DNA’s website for
30 days.
About Codex DNA
Codex DNA is empowering scientists with the ability to create
novel, synthetic biology solutions for many of humanity’s greatest
challenges. As inventors of the industry-standard Gibson Assembly®
method and the first commercial automated benchtop DNA and mRNA
synthesis system, Codex DNA is enabling rapid, accurate, and
reproducible writing of DNA and mRNA for numerous downstream
markets. The company’s award-winning BioXp™ system consolidates,
automates, and optimizes the entire synthesis, cloning, and
amplification workflow. As a result, it delivers virtually
error-free synthesis of DNA/RNA at scale within days and hours
instead of weeks or months. Scientists around the world are using
the technology in their own laboratories to accelerate the
design-build-test paradigm for novel, high-value products for
precision medicine, biologics drug discovery, vaccine and
therapeutic development, genome editing, and cell and gene therapy.
Codex DNA is a public company based in San Diego. For more
information, visit codexdna.com.Contact:Richard
LepkeDirector of Investor Relations(619)
840-5392RichardL@codexdna.com
Codex DNA (NASDAQ:DNAY)
Historical Stock Chart
From Jul 2024 to Aug 2024
Codex DNA (NASDAQ:DNAY)
Historical Stock Chart
From Aug 2023 to Aug 2024